$CRDL looks interesting here and may bounce back anytime. The stock is already up 173% YTD and pulled back about 10% from multi-year high on a very low volume. Analysts have released bullish commentary on the stock as high as $9 PT.
Last week, Canaccord Genuity lifted the PT to $8 from $6 on Cardiol Therapeutics Inc (NASDAQ: CRDL) – Potential gain of 230% from CMP.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.